| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 44 |
| 1 | UPADACITINIB | 41 |
| 2 | GABAPENTIN | 35 |
| 3 | ERGOCALCIFEROL | 23 |
| 4 | RISANKIZUMAB-RZAA | 22 |
| 5 | PREGABALIN | 21 |
| 6 | ETANERCEPT | 20 |
| 7 | OXYCODONE HYDROCHLORIDE | 18 |
| 8 | ASPIRIN | 16 |
| 9 | ASPIRIN 325 MG | 16 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | IBUPROFEN AND DIPHENHYDRAMINE HCL | 1 | 0.0139 |
| 1 | DIPHENHYDRAMINE CITRATE, IBUPROFEN | 1 | 0.0128 |
| 2 | TETRAHYDROZOLINE HYDROCHLORIDE | 1 | 0.0034 |
| 3 | OMEPRAOLE, SODIUM BICARBONATE | 1 | 0.0031 |
| 4 | EFGARTIGIMOD ALFA AND HYALURONIDASE (HUMAN RECOMBINANT) | 1 | 0.0021 |
| 5 | AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE | 1 | 0.0015 |
| 6 | OXAPROZIN | 1 | 0.0011 |
| 7 | OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN | 13 | 0.0011 |
| 8 | OMEPRAZOLE, SODIUM BICARBONATE | 1 | 0.0010 |
| 9 | PLECANATIDE | 2 | 0.0010 |
| # | Drug class | Count |
|---|---|---|
| 0 | Janus Kinase Inhibitor [EPC] | 43 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 36 |
| 2 | Tumor Necrosis Factor Blocker [EPC] | 36 |
| 3 | Benzodiazepine [EPC] | 27 |
| 4 | Provitamin D2 Compound [EPC] | 23 |
| 5 | Interleukin-23 Antagonist [EPC] | 22 |
| 6 | Opioid Agonist [EPC] | 21 |
| 7 | Vitamin C [EPC] | 20 |
| 8 | Corticosteroid [EPC] | 19 |
| 9 | Platelet Aggregation Inhibitor [EPC] | 16 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Guanylate Cyclase-C Agonist [EPC] | 4 | 0.0019 |
| 1 | Provitamin D2 Compound [EPC] | 23 | 0.0008 |
| 2 | Endoglycosidase [EPC] | 1 | 0.0005 |
| 3 | Neonatal Fc Receptor Blocker [EPC] | 2 | 0.0005 |
| 4 | Hydrolytic Lysosomal Glycogen-specific Enzyme [EPC] | 1 | 0.0003 |
| 5 | Calcitonin Gene-related Peptide Receptor Antagonist [EPC] | 2 | 0.0003 |
| 6 | Janus Kinase Inhibitor [EPC] | 43 | 0.0003 |
| 7 | Sulfonamide Antibacterial [EPC] | 1 | 0.0003 |
| 8 | Antiseptic [EPC] | 1 | 0.0002 |
| 9 | Sympathomimetic-like Agent [EPC] | 7 | 0.0002 |